ArticleEndocrinology2013

Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.

Alessio Giubellino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.